September 20, 2017 3:44 AM ET

Pharmaceuticals

Company Overview of Sanomune Inc.

Company Overview

Sanomune Inc. operates as a biopharmaceutical company that develops products for treatment of neurological and autoimmune disorders. The company’s products include SAN-61, which is used for the treatment of alzheimer's disease; SAN-121, which is nasally-delivered metal chelator that reduces cognitive decline in alzheimer's patients; and SAN-18, which is used for the treatment of rheumatoid arthritis. Its products are also used for treating multiple sclerosis and diabetes. The company was founded in 1999 and is based in Winnipeg, Canada. As of June 30, 2010, Sanomune Inc. operates as a subsidiary of Diamedica Inc.

7-1250 Waverley Street

Winnipeg, MB R3T 6C6

Canada

Founded in 1999

Phone:

204-453-1230

Fax:

204-453-1293

Key Executives for Sanomune Inc.

Sanomune Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
1127466 B.C. Ltd. Americas
4everPets Ltd. Americas
9037136 Canada Inc. Americas
AAA Heidelberg Inc. Americas
Ab Biotech Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sanomune Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.